Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesSafety, efficacy, and pharmacokinetics of intravenous busulfan in children undergoing allogeneic hematopoietic stem cell transplantation
Pediatric Blood & Cancer, 09/29/09
Wall DA et al. – All children were engrafted with documented donor chimerism. No late rejections or graft failures occurred. Four patients had veno–occlusive disease, three of which resolved within 2 weeks of onset. Two children died from transplant–related causes unrelated to Bu. IVBu is a safe and effective and offers the benefit of predictable and consistent systemic exposure.
Related Articles
Reduced-intensity conditioned allogeneic haematopoietic stem cell transplantation results in durable disease-free and overall survival in patients with poor prognosis myeloid and lymphoid malignancies: Eighty-month follow-up
Bone Marrow Transplantation, 11/13/09
Relevance Score: 83%
Regulatory T Cell (Treg) Subsets Return in Patients with Refractory Lupus following Stem Cell Transplantation, and TGF-[beta]-Producing CD8+ Treg Cells Are Associated with Immunological Remission of Lupus
Journal of Immunology, 11/10/09
Relevance Score: 82%
Natural killer cells - new understanding of basic biology may lead to more effective allogeneic haematopoietic stem cell transplantation
Internal Medicine Journal, 10/21/09
Relevance Score: 82%
Primary cutaneous T-cell lymphoproliferative disorder of donor origin after allogeneic haematopoietic stem-cell transplantation
Clinical and Experimental Dermatology, 10/16/09
Relevance Score: 82%
History of cord blood transplantation
Bone Marrow Transplantation, 10/07/09
Relevance Score: 82%
Today in Pharmacokinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Population pharmacokinetics of posaconazole in neutropenic patients receiving chemotherapy for acute myelogenous leukemia or myelodysplastic syndrome
Current Medical Research and Opinion, 12/17/09
Evaluation of Anti-HBs Serum Levels and Pharmacokinetic Profile After Intravenous Administration of Niuliva, a New Hepatitis B Immunoglobulin, Following Liver Transplantation
Transplantation Proceedings, 12/17/09
A phase I/II dose escalation study of apolizumab (Hu1D10) using a stepped-up dosing schedule in patients with chronic lymphocytic leukemia and acute leukemia
Leukemia and Lymphoma, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor